Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival
2007
HTLV-1 p30 and T-cell Survival
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Antara Datta, Lee Silverman, Andrew Phipps, Hajime Hiraragi, Lee Ratner, Michael D. Lairmore
Primary Institution: The Ohio State University
Hypothesis
Does HTLV-1 p30 expression affect the cell cycle regulation and survival of T-lymphocytes?
Conclusion
HTLV-1 p30 expression enhances T-cell survival by modulating cell cycle regulation.
Supporting Evidence
- p30 expression in Jurkat T-cells resulted in increased accumulation in the G2-M phase of the cell cycle.
- Jurkat T-cells expressing p30 showed enhanced phosphorylation of Cdc25C at serine 216.
- Primary human lymphocyte derived cell lines lacking p30 were more susceptible to camptothecin-induced apoptosis.
Takeaway
The study shows that a protein from the HTLV-1 virus helps T-cells live longer by changing how they grow and divide.
Methodology
Jurkat T-cells were transduced with a p30 expressing lentivirus vector and analyzed for cell cycle progression and apoptosis susceptibility.
Limitations
The study primarily focuses on Jurkat T-cells and may not fully represent primary human T-cells.
Statistical Information
P-Value
0.02
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website